TickerFacts.

A business in context

CRSP research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-07 · 0001193125-26-345111

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-330672

  3. 8-K · Current report

    Report date 2026-08-03 · 0001193125-26-330644 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-264390

  5. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-264382

  6. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-264290

  7. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-264289

  8. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-264288

  9. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-264287

  10. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-264286

  11. 8-K · Current report

    Report date 2026-06-04 · 0001193125-26-257593 · Items 5.02,5.03,5.07,9.01

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-204188

  13. 8-K · Current report

    Report date 2026-05-04 · 0001193125-26-204147 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-04 · 0001193125-26-165158

  15. 8-K · Current report

    Report date 2026-03-16 · 0001193125-26-108333 · Items 1.01,2.03,3.02,9.01

  16. 8-K · Current report

    Report date 2026-03-10 · 0001193125-26-101073 · Items 8.01,9.01

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-048957

  18. 8-K · Current report

    Report date 2026-02-12 · 0001193125-26-048873 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-009880 · Items 8.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-273337

  21. 8-K · Current report

    Report date 2025-11-10 · 0001193125-25-273329 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-10-15 · 0001193125-25-240282 · Items 8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-102052

  24. 8-K · Current report

    Report date 2025-08-04 · 0000950170-25-102027 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-26 · 0000950170-25-090170 · Items 8.01

  26. 8-K · Current report

    Report date 2025-06-05 · 0000950170-25-083799 · Items 5.03,5.07,9.01

  27. 8-K · Current report

    Report date 2025-05-19 · 0000950170-25-074428 · Items 1.01,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-064468

  29. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-064435 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0000950170-25-054711

  31. 8-K · Current report

    Report date 2025-03-24 · 0000950170-25-045232 · Items 5.02,9.01

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-017899

  33. 8-K · Current report

    Report date 2025-02-11 · 0000950170-25-017879 · Items 2.02,9.01

  34. SC 13G/A · Ownership disclosure

    0001104659-24-127131

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-121105

  36. 8-K · Current report

    Report date 2024-11-05 · 0000950170-24-121103 · Items 2.02,9.01

  37. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-090746

  38. 8-K · Current report

    Report date 2024-08-05 · 0000950170-24-090727 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-05-30 · 0000950170-24-067660 · Items 5.02,5.03,5.07,9.01

  40. 8-K · Current report

    Report date 2024-05-23 · 0000950123-24-005877 · Items 5.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 13 transaction rows13AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

16 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-05
2026-06-09
George SimeonA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Behbahani AliA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Fardis MariaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Fleming Harold EdwardA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Greene JohnA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
High Katherine AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Mahatme SandeshA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Morrison BriggsA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Rommel ChristianA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-06-05
2026-06-09
Treco Douglas AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13000.00.0
2026-05-29
2026-06-02
KASINGER JAMES R.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
17000.00.0
2026-05-29
2026-06-02
Patel NaimishA · Grant / award
Acquired
Restricted Stock Units
Derivative security
22000.00.0
2026-05-29
2026-06-02
Prasad RajuA · Grant / award
Acquired
Restricted Stock Units
Derivative security
19500.00.0
2026-05-29
2026-06-01
Patel NaimishS · Sale
Disposed
Common Shares3786.055.62
2026-05-28
2026-06-01
Patel NaimishM · Exercise / conversion
Acquired
Common Shares10000.0—
2026-05-28
2026-06-01
Patel NaimishM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
10000.0—

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001674416CRISPR Therapeutics AG

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
506700O6IRRIQLT3W370
GLEIF legal name
CRISPR Therapeutics AG
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-01-09T14:20:20Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • CRISPR Therapeutics · alias · wikidata
  • CRISPR Therapeutics AG · former SEC name · 2016-05-13 to 2026-08-14
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$37.31M$39.72M
2023-12-31$371.21M$406.77M
2022-12-31$1.20M$1.37M
2021-12-31$914.96M$1.13B
2020-12-31$719.0K$927.6K
2019-12-31$289.59M$378.22M
2018-12-31$3.12M$4.15M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗